Peptide harm reduction (revision 3)
Old revision·05:27, 7 Dec 2024·CDMO_Caradoc
| Peptide harm reduction | |
|---|---|
| Principle | Reduce harm without requiring abstinence |
| Applied to | Material of uncertain identity, content and sterility |
| Limit | Information is not a substitute for regulated supply |
| Topic infobox · conventions | |
Peptide harm reduction applies harm-reduction principles — reducing harm among people engaged in a practice, without requiring that they stop — to the situation of people obtaining peptides outside regulated supply.[1]
The uncertainties are specific and documented elsewhere on this wiki: identity, which a purity figure does not establish; content, which determines how much active substance a vial holds; sterility, which a research-chemical powder does not have; and provenance, which determines whether any document attaches to the material at all.[2]
What the uncertainties are
[edit]| Uncertainty | Resolved by | Commonly reported? |
|---|---|---|
| Identity | Mass spectrometry confirmation | Sometimes |
| Purity | Named chromatographic method | Usually |
| Content | Peptide content, water, counterion | Rarely |
| Fill mass | Gravimetric check | Rarely |
| Sterility | Sterility testing; not applicable to research powders | No |
| Endotoxin | Bacterial endotoxin test | Rarely |
| Provenance | Lot traceability records | Variable |
The row that matters most and is reported least is content. Without it the mass of peptide in a vial is unknown, and every downstream quantity — concentration after reconstitution, volume drawn, exposure — inherits that unknown.[2]